Regulatory T Cells and Profile of FOXP3 Isoforms Expression in Peripheral Blood of Patients with Myelodysplastic Syndromes.

Autor: Dudina GA; Loginov Moscow Clinical Center of the Moscow Health Department, 111123 Moscow, Russia., Donetskova AD; National Research Center-Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia.; Pirogov Russian National Research Medical University, 117997 Moscow, Russia., Litvina MM; National Research Center-Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia., Mitin AN; National Research Center-Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia., Mitina TA; Moscow Regional Research Clinical Institute Named after MF Vladimirsky, 129110 Moscow, Russia., Polyakov SA; Celgene International Holdings Corporation, 125047 Moscow, Russia.
Jazyk: angličtina
Zdroj: Advances in hematology [Adv Hematol] 2018 Oct 10; Vol. 2018, pp. 8487403. Date of Electronic Publication: 2018 Oct 10 (Print Publication: 2018).
DOI: 10.1155/2018/8487403
Abstrakt: We have investigated the frequencies of regulatory T cells and the level of FOXP3 isoforms expression in peripheral blood of patients with myelodysplastic syndromes and found the significant reduction of regulatory T cells at all stages of the disease. At the same time in untreated patients, we observed the shift in the FOXP3 isoforms expression profile towards the full-length molecule possibly due to inflammation. Based on the already known information about the potentially higher functional activity of FOXP3 molecule lacking exon 2, we have also hypothesized that our finding may explain the high risk of autoimmune disorders in this disease.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje